Vera Therapeutics (VERA) Share-based Compensation Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | 70.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.56% |
| Dec 31, 2025 | 76.37% |
| Sep 30, 2025 | 74.39% |
| Jun 30, 2025 | 94.38% |
| Mar 31, 2025 | 87.78% |
| Dec 31, 2024 | 93.01% |
| Sep 30, 2024 | 91.17% |
| Jun 30, 2024 | 81.69% |
| Mar 31, 2024 | 54.63% |
| Dec 31, 2023 | 17.21% |
| Sep 30, 2023 | 19.21% |
| Jun 30, 2023 | 32.44% |
| Mar 31, 2023 | 60.47% |
| Dec 31, 2022 | 185.65% |
| Sep 30, 2022 | 162.81% |
| Jun 30, 2022 | 184.01% |
| Mar 31, 2022 | 311.39% |
| Dec 31, 2021 | 572.73% |
| Sep 30, 2021 | 1,596.36% |
| Jun 30, 2021 | 6,381.82% |
| Mar 31, 2021 | 562.30% |